SF3B1 Protein

SF3B1 Protein

Overview

SF3B1 (Splicing Factor 3b Subunit 1) is a core component of the spliceosome, the large ribonucleoprotein complex responsible for removing introns from precursor messenger RNA (pre-mRNA) and joining exons to produce mature mRNA. As part of the U2 small nuclear ribonucleoprotein (snRNP) complex, SF3B1 functions as a critical scaffolding and catalytic protein essential for accurate pre-mRNA splicing in all eukaryotic cells. The protein is encoded by the SF3B1 gene located on chromosome 22q13.2 and is approximately 145 kilodaltons in molecular weight. SF3B1 is highly conserved across species, underscoring its fundamental importance to cellular gene expression machinery. Mutations and dysregulation of SF3B1 have been implicated in various cancers and increasingly recognized as relevant to neurodegenerative pathologies, particularly those involving RNA processing dysfunction.

Function/Biology

SF3B1 Protein

Overview

SF3B1 (Splicing Factor 3b Subunit 1) is a core component of the spliceosome, the large ribonucleoprotein complex responsible for removing introns from precursor messenger RNA (pre-mRNA) and joining exons to produce mature mRNA. As part of the U2 small nuclear ribonucleoprotein (snRNP) complex, SF3B1 functions as a critical scaffolding and catalytic protein essential for accurate pre-mRNA splicing in all eukaryotic cells. The protein is encoded by the SF3B1 gene located on chromosome 22q13.2 and is approximately 145 kilodaltons in molecular weight. SF3B1 is highly conserved across species, underscoring its fundamental importance to cellular gene expression machinery. Mutations and dysregulation of SF3B1 have been implicated in various cancers and increasingly recognized as relevant to neurodegenerative pathologies, particularly those involving RNA processing dysfunction.

Function/Biology

SF3B1 operates as part of the U2 snRNP particle, which is essential for the recognition and catalysis of the 2′-intron branch point during the spliceosome assembly process. Structurally, SF3B1 contains multiple HEAT repeats (huntingtin, elongation factor 3, protein phosphatase 2A, and TOR kinase repeats) that facilitate protein-protein interactions and form a platform for other spliceosomal components. The protein specifically assists in anchoring the U2 snRNA to the branch point sequence upstream of the 3′-intron splice site. SF3B1 also interacts with SF3B3, SF3B4, and other components of the U2 snRNP complex to maintain proper splicing fidelity. Beyond canonical splicing, SF3B1 participates in alternative splicing regulation, allowing cells to generate protein diversity from a limited genome. The protein is constitutively expressed across virtually all cell types and tissues, with particularly high levels in neurons where metabolic demands and complexity of gene expression are substantial.

Role in Neurodegeneration

While SF3B1 mutations are classically associated with retinitis pigmentosa and myelodysplastic syndromes rather than primary neurodegenerative diseases, growing evidence suggests splicing dysfunction generally contributes to neurodegeneration pathology. In Alzheimer's disease, dysregulation of splicing patterns has been documented, and several neurodegenerative conditions show altered expression of spliced isoforms relevant to disease pathology. Emerging research indicates that impaired splicing efficiency may exacerbate protein aggregation diseases by producing truncated or misfolded proteins that accumulate in the brain. Additionally, splicing defects can impair the production of proteins critical for neuronal maintenance and synaptic function. The neuroinflammatory component of neurodegeneration may be influenced by aberrant splicing of genes involved in immune regulation, potentially affecting disease progression through alterations in SF3B1 activity or expression.

Molecular Mechanisms

SF3B1 functions through recruitment and stabilization of the U2 snRNP complex at the branch point consensus sequence (typically YRAC, where Y is pyrimidine, R is purine, A is adenine, and C is cytosine). The protein facilitates a conformational change in U2 snRNA that positions the reactive adenosine residue for 2′-OH-mediated transesterification reactions. Pathogenic mutations in SF3B1 typically cluster in the HEAT repeat regions and alter branch point recognition, leading to cryptic splice site usage or intron retention. At the molecular level, disrupted SF3B1 function reduces splicing precision, potentially generating aberrant transcripts with functional consequences. In neurons specifically, splicing errors affecting genes encoding synaptic proteins, cytoskeletal components, or proteostasis factors could contribute to neuronal dysfunction and vulnerability to degeneration.

Clinical/Research Significance

SF3B1 mutations cause retinitis pigmentosa type 11, characterized by progressive photoreceptor degeneration, demonstrating tissue-specific vulnerability to splicing defects. Recent neurodegeneration research examines whether common SF3B1 variants or altered expression contribute to disease susceptibility or progression. Understanding SF3B1 function provides mechanistic insights into RNA processing dysfunction in neurodegeneration and potential therapeutic targets through splicing modulation.

Related Entities

• Spliceosome: The catalytic ribonucleoprotein machinery containing SF3B1
• U2 snRNP: The specific complex where SF3B1 functions
• Pre-mRNA Splicing: The process SF3B1 enables
• Alternative Splicing: Variable splicing patterns influenced by SF3B1 regulation
• Retinitis Pigmentosa: Genetic disorder caused by SF3B1 mutations
• RNA Processing Dysfunction: Broader category of molecular defects in neurodegeneration